TI
MYOK

Trexquant Investment’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Trexquant Investment’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,784
Closed -$269K – 1661
2020
Q2 		$269K Sell
2,784
-27,274
-91% -$2.28M 0.02% 932
2020
Q1 		$1.41M Buy
30,058
+20,777
+224% +$1.33M 0.1% 302
2019
Q4 		$676K Sell
9,281
-3,298
-26% -$200K 0.04% 471
2019
Q3 		$656K Buy
+12,579
New +$669K 0.06% 382
2019
Q2 		– Sell
-30,971
Closed -$1.61M – 1273
2019
Q1 		$1.61M Buy
+30,971
New +$1.43M 0.11% 262
2017
Q3 		– Sell
-13,100
Closed -$172K – 1130
2017
Q2 		$172K Sell
13,100
-24,887
-66% -$328K 0.05% 696
2017
Q1 		$500K Buy
37,987
+21,787
+134% +$279K 0.06% 539
2016
Q4 		$210K Buy
+16,200
New +$250K 0.03% 799

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Trexquant Investment's MYOK Position: Q3 2020 in Review

Trexquant Investment sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 2,784 shares — an estimated $269K sold.

Trexquant Investment first reported a position in MYOK in Q4 2016 and held it in 8 quarters. The position peaked at $1.61M in Q1 2019. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Trexquant Investment reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Trexquant Investment sold 2,784 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $269K.
  • Trexquant Investment first reported a position in MyoKardia, Inc. Common Stock in Q4 2016 and held it in 8 quarters.
  • Trexquant Investment's MyoKardia, Inc. Common Stock position peaked at $1.61M in Q1 2019.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Trexquant Investment's 13F filing for Q3 2020, filed 6 Nov 2020.